Maral Anjomanibenisi

Feline nasal carcinomas are rare but clinically aggressive neoplasms. This study characterizes their histopathological features and evaluates HER2, p53, Ki-67, and PCNA expression using immunohistochemistry and digital image analysis, aiming to provide a comprehensive biological characterization with potential prognostic and therapeutic implications. Tumors were classified into adenocarcinomas (AC) and non-adenocarcinomas (non-AC). Among the 23 cases examined, adenocarcinoma was the most common subtype (17 cases). HER2 was scored as 3+ in 7 cases, 2+ in 8 cases, 1+ in 5 cases, and 3 cases were scored 0. A statistically significant association was found between histological type and HER2 expression (Fisher’s exact test, p = 0.02), with a higher prevalence of HER2 positivity in adenocarcinomas. Evaluation of p53 expression according to histological grouping showed a trend toward significance (p = 0.0593), with p53 positivity observed exclusively in non-AC. The Ki-67 index had a median of 4.4 (min 0.5, max 21.06), and the PCNA index had a median of 82.26 (min 19.55, max 100). No significant associations were identified between the Ki-67 labeling index and HER2 expression, histotype, and the inflammatory infiltrate. Finally, Pearson correlation analysis revealed no significant correlation between Ki-67 and PCNA indices (p = 0.32). The overexpression of HER2 lays the groundwork for the possible use of anti-HER2 targeted drugs in this tumor type, particularly in adenocarcinomas. These findings provide baseline immunohistochemical data for feline nasal carcinomas and highlight HER2 as a relevant biomarker for future diagnostic and therapeutic research.